percent of the market price of the Company’s shares. In this regard, “market price” shall mean the weighted average price of the Company’s shares trading on the stock exchange of not fewer seven consecutive
this regard, “market price” shall mean the weighted average price of the Company’s shares trading on the stock exchange of not fewer seven consecutive business days but not more than fifteen consecutive
Company’s shares trading on the stock exchange of not fewer seven consecutive business days prior to the date that the Board of Directors’ of the company has resolved to propose Shareholders’ Meeting to
Remarks: 1. The Company may either entirely or partially allocate the newly issued ordinary shares, whether in single or sequential allocation. In any case, the aggregate number of newly issued ordinary
allocate the newly issued ordinary shares, whether in single or sequential allocation. In any case, the aggregate number of newly issued ordinary shares to be allocated to specific persons under the Private
but not limited to: (1) allocating the newly issued ordinary shares whether in a single or sequential allocations, determining the period of the offering, payment, conditions and other details in
another record quarter that makes 14 consecutive quarters of core EPS growth on a Last Twelve Month (LTM) basis. Core EBITDA 2Q17 up 9% and LTM 2Q17 up 33% Core EBIT (Operating Profit) up 14% in 2Q17
weighted average market price per share of the Company’s ordinary shares traded in the SET for retroactively 7 business days but not more than 15 consecutive business days prior to the date to determine the
No. TorChor. 72/2558”), calculated from the weighted average market price per share of the Company’s ordinary shares traded in the SET for retroactively 7 business days but not more than 15 consecutive
No. TorChor. 72/2558”), calculated from the weighted average market price per share of the Company’s ordinary shares traded in the SET for retroactively 7 business days but not more than 15 consecutive